,in the ,senate of the ,united ,states1 ,december #aa1 #bjbj4 ,amendment3 ,that the bill from the ,house of ,representatives 7,h4,r4 #dgfd7 entitled ,an ,act to reauthorize the ,stem ,cell ,therapeutic and ,research ,act of #bjje1 and for other purposes41 do pass with the following ,strike all after the enacting clause and insert the following3 #a4 ,short title ,this ,act may be cited as the ,timely ,re,authorization of ,necessary ,stem-cell ,programs ,lends ,access to ,needed ,therapies ,act of #bjbj or the ,,transplant ,act of #bjbj4 #b4 ,reauthorization of the ,c4,w4 ,bill ,young ,cell ,transplantation ,program 7a7 ,advisory council meetings ,subsection 7a7 of section #cgi of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bgdk7 is amended by adding at the end the following new paragraph3 7#g7 ,the ,secretary shall convene the ,advisory ,council at least two times each calendar year4 4 7b7 ,increasing collection 7#a7 ,technical clarification ,effective as if included in the enactment of ,public ,law #aad-ajd 7the ,stem ,cell ,therapeutic and ,research ,reauthorization ,act of #bjae71 the amendment to section #cgi7;d77#b77;,b7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bgdk7d77#b77;,b77 in section #b7;a77#b7 of ,public ,law #aad-ajd is amended by inserting goal of increasing collections of high quality before cord blood units14 7#b7 ,eliminating deadwood ,subparagraph 7,b7 of section #cgi7;d77#b7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bgdk7d77#b77 is amended by striking the second and third sentences in such subparagraph4 7c7 ,periodic review of state of science ,section #cgi of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bgdk7 is amended by adding at the end the following new subsection3 7o7 ,periodic review of state of science 7#a7 ,review ,not less than every two years1 the ,secretary1 in consultation with the ,director of the ,national ,institutes of ,health1 the ,commissioner of ,food and ,drugs1 the ,administrator of the ,health ,resources and ,services ,administration1 the ,advisory ,council1 and other stakeholders1 where appropriate given relevant expertise1 shall conduct a review of the state of the science of using adult stem cells and birthing tissues to develop new types of therapies for patients1 for the purpose of considering the potential inclusion of such new types of therapies in the ,program4 7#b7 ,recommendations ,not later than ,june #cj1 #bjbd1 the ,secretary shall-- 7,a7 complete the second review required by paragraph 7#a72 and 7,b7 informed by such review1 submit to the ,committee on ,health1 ,education1 ,labor1 and ,pensions of the ,senate and the ,committee on ,energy and ,commerce of the ,house of ,representatives recommendations on the appropriateness of the inclusion of new types of therapies in the ,program4 4 7d7 ,authorization of appropriations ,section #cgi;,b of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bgdm7 is amended by striking #cc1jjj1jjj for fiscal year #bjae and #cj1jjj1jjj for each of fiscal years #bjaf through #bjbj and inserting #cj1jjj1jjj for each of fiscal years #bjba through #bjbe4 #c4 ,cord blood inventory ,subsection 7g7 of section #b of the ,stem ,cell ,therapeutic and ,research ,act of #bjje 7#db ,u4,s4,c4 #bgdk note7 is amended to read as follows3 7g7 ,authorization of appropriations ,to carry out this section1 there is authorized to be appropriated #bc1jjj1jjj for each of fiscal years #bjba through #bjbe4 4 #d4 ,advancing the field of regenerative medicine ,section #djb of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bhb7 is amended by adding at the end the following3 7o7 ,regenerative ,medicine ,the ,director of ,,nih shall1 as appropriate1 continue to consult with the directors of relevant institutes and centers of the ,national ,institutes of ,health1 other relevant experts from such institutes and centers1 and relevant experts within the ,food and ,drug ,administration1 to further the field of regenerative medicine using adult stem cells1 including autologous stem cells1 therapeutic tissue engineering products1 human cell and tissue products1 human gene therapies1 and genetically modified cells4 4 #e4 ,,gao report on regenerative medicine workforce ,not later than #b years after the date of enactment of this ,act1 the ,comptroller ,general of the ,united ,states shall submit to the ,committee on ,health1 ,education1 ,labor1 and ,pensions of the ,senate and the ,committee on ,energy and ,commerce of the ,house of ,representatives a report that assesses a specialized health care workforce in the field of regenerative medicine4 ,the report shall include-- 7#a7 an overview of the current employment levels1 in both commercial and academic settings1 for-- 7,a7 positions necessary for the collection and transplantation of stem cell therapeutics1 including bone marrow and cord blood2 and 7,b7 positions in the field of regenerative medicine using adult stem cells and related to product development2 7#b7 the identification of gaps1 if any1 in the projected workforce capacity for-- 7,a7 positions described in paragraph 7#a77;,a72 and 7,b7 the field of regenerative medicine using adult stem cells1 including workforce gaps related to the development of new cellular therapies using adult stem cells2 7#c7 an overview of the availability of training programs related to the development1 refinement1 and utilization of adult stem cells1 including training on good manufacturing practices for such activities1 and the performance of such programs2 and 7#d7 recommendations1 if any1 for improving the workforce capacity related to-- 7,a7 the positions described in paragraph 7#a77;,a72 or 7,b7 the field of regenerative medicine using adult stem cells4 ,secretary